Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Poly(ortho esters) - their development and some recent applications.

J Heller1, J Barr, S Y Ng

  • 1Advanced Polymer Systems, Redwood City, CA 94063, USA. jheller6@compuserve.com

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V
|June 7, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Efficacy and safety analysis of BTK inhibitors combined with R-CHOP regimen in newly diagnosed double-expressor diffuse large B-cell lymphoma].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026
Same author

First Demonstration of Resonant Pitch-Angle Scattering of Relativistic Electrons by Externally Launched Helicon Waves.

Physical review letters·2026
Same author

[Effect and safety of a conditioning regimen with chidamide and BEAM for autologous hematopoietic stem cell transplantation in lymphoma].

Zhonghua nei ke za zhi·2025
Same author

[Efficacy and safety of PEMD regimen in newly diagnosed early-stage non-upper respiratory digestive tract or advanced extranodal natural killer/T-cell lymphoma].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2025
Same author

[The efficacy and safety of thioamide in maintenance therapy for peripheral T-cell lymphoma].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2025
Same author

[Efficacy and safety analysis of the OR-CHOP regimen for the treatment of MCD subtype diffuse large B cell lymphoma in the real-world setting].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2024

Poly(ortho esters) show promise in medical applications. Poly(ortho ester) IV offers a stable, biocompatible, and reproducible option for drug delivery and treatment, unlike poly(ortho ester) III.

Area of Science:

  • Polymer Chemistry and Biomaterials Science
  • Biocompatible Polymers
  • Drug Delivery Systems

Background:

  • Poly(ortho esters) (POEs) have been developed since the 1970s, with four main families identified.
  • Two POE families, POE III and POE IV, are of particular interest due to their biocompatibility.
  • POE III is a semisolid material explored for ocular applications, including glaucoma surgery adjuncts.

Purpose of the Study:

  • To review the development and applications of poly(ortho ester) III and poly(ortho ester) IV.
  • To highlight the advantages and limitations of each polymer family for biomedical use.
  • To discuss the potential of POE IV in diverse therapeutic areas.

Main Methods:

  • Review of existing literature on poly(ortho ester) synthesis and characterization.

Related Experiment Videos

  • Evaluation of biocompatibility data for POE III and POE IV.
  • Analysis of polymerization control, stability, and scalability for both polymer types.

    • Main Results:

    • Poly(ortho ester) III exhibits high biocompatibility for ocular applications but faces challenges in controlled polymerization and scalability.
    • Poly(ortho ester) IV demonstrates high biocompatibility, stability (when moisture is excluded), and reproducible preparation.
    • POE IV is under development for ocular delivery, protein release, and post-operative pain and cancer treatment.

    Conclusions:

    • Poly(ortho ester) IV presents a more viable and versatile option for biomedical applications compared to POE III due to its ease of preparation and stability.
    • The biocompatibility and tunable properties of POE IV position it as a promising material for advanced therapeutic delivery systems.
    • Further research and development of POE IV are warranted for its successful clinical translation.